Literature DB >> 10639409

Host cellular immune response to pneumococcal lung infection in mice.

A Kadioglu1, N A Gingles, K Grattan, A Kerr, T J Mitchell, P W Andrew.   

Abstract

Although there is substantial evidence that pneumolysin is an important virulence factor in pneumococcal pneumonia, relatively little is known about how it influences cellular infiltration into the lungs. We investigated how the inability of mutant pneumococci to produce pneumolysin altered the pattern of inflammation and cellular infiltration into the lungs. The effect on bacterial growth in the lungs also was assessed. There were three phases of growth of wild-type bacteria in the lungs: a decline followed by a rapid increase and then stasis or decline. The absence of pneumolysin was associated with a more rapid early decline and then a much slower increase in numbers. The pattern of inflammatory-cell accumulation also had distinct stages, and the timing of these stages was influenced by the presence of pneumolysin. Neutrophils began to accumulate about 12 to 16 h after infection with wild-type pneumococci. This accumulation occurred after the early decline in pneumococcal numbers but coincided with the period of rapid growth. Following infection with pneumococci unable to make pneumolysin, neutrophil influx was slower and less intense. Coincident with the third stage of pneumococcal growth was an accumulation of T and B lymphocytes at the sites of inflammation, but the accumulation was not associated with an increase in the total number of lymphocytes in the lungs. Lymphocyte accumulation in the absence of pneumolysin occurred but was delayed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10639409      PMCID: PMC97168          DOI: 10.1128/IAI.68.2.492-501.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  The effect of Streptococcus pneumoniae pneumolysin on human respiratory epithelium in vitro.

Authors:  C Feldman; T J Mitchell; P W Andrew; G J Boulnois; R C Read; H C Todd; P J Cole; R Wilson
Journal:  Microb Pathog       Date:  1990-10       Impact factor: 3.738

2.  Preparation of interstitial lung cells by enzymatic digestion of tissue slices: preliminary characterization by morphology and performance in functional assays.

Authors:  P G Holt; A Degebrodt; T Venaille; C O'Leary; K Krska; J Flexman; H Farrell; G Shellam; P Young; J Penhale
Journal:  Immunology       Date:  1985-01       Impact factor: 7.397

3.  Steroid pulse therapy for rheumatoid arthritis: effect on lymphocyte subsets and mononuclear cell adhesion.

Authors:  A Kadioglu; P Sheldon
Journal:  Br J Rheumatol       Date:  1998-03

4.  Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae.

Authors:  A M Berry; J Yother; D E Briles; D Hansman; J C Paton
Journal:  Infect Immun       Date:  1989-07       Impact factor: 3.441

5.  Localization of T cells, macrophages and dendritic cells in rat respiratory tract tissue: implications for immune function studies.

Authors:  P G Holt; M A Schon-Hegrad
Journal:  Immunology       Date:  1987-11       Impact factor: 7.397

6.  Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity, and migration by pneumolysin.

Authors:  J C Paton; A Ferrante
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

7.  The interaction of Streptococcus pneumoniae with intact human respiratory mucosa in vitro.

Authors:  C Feldman; R Read; A Rutman; P K Jeffery; A Brain; V Lund; T J Mitchell; P W Andrew; G J Boulnois; H C Todd
Journal:  Eur Respir J       Date:  1992-05       Impact factor: 16.671

8.  Complement activation and antibody binding by pneumolysin via a region of the toxin homologous to a human acute-phase protein.

Authors:  T J Mitchell; P W Andrew; F K Saunders; A N Smith; G J Boulnois
Journal:  Mol Microbiol       Date:  1991-08       Impact factor: 3.501

9.  Inhibition of human monocyte respiratory burst, degranulation, phospholipid methylation and bactericidal activity by pneumolysin.

Authors:  M Nandoskar; A Ferrante; E J Bates; N Hurst; J C Paton
Journal:  Immunology       Date:  1986-12       Impact factor: 7.397

10.  Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes.

Authors:  S Houldsworth; P W Andrew; T J Mitchell
Journal:  Infect Immun       Date:  1994-04       Impact factor: 3.441

View more
  92 in total

1.  Pneumolysin potentiates production of prostaglandin E(2) and leukotriene B(4) by human neutrophils.

Authors:  R Cockeran; H C Steel; T J Mitchell; C Feldman; R Anderson
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  The putative proteinase maturation protein A of Streptococcus pneumoniae is a conserved surface protein with potential to elicit protective immune responses.

Authors:  K Overweg; A Kerr; M Sluijter; M H Jackson; T J Mitchell; A P de Jong; R de Groot; P W Hermans
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

Review 3.  Listeriolysin O: A phagosome-specific cytolysin revisited.

Authors:  Brittney N Nguyen; Bret N Peterson; Daniel A Portnoy
Journal:  Cell Microbiol       Date:  2019-01-15       Impact factor: 3.715

4.  Role of HtrA in the virulence and competence of Streptococcus pneumoniae.

Authors:  Yasser Musa Ibrahim; Alison R Kerr; Jackie McCluskey; Tim J Mitchell
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

5.  The Ami-AliA/AliB permease of Streptococcus pneumoniae is involved in nasopharyngeal colonization but not in invasive disease.

Authors:  A R Kerr; P V Adrian; S Estevão; R de Groot; G Alloing; J-P Claverys; T J Mitchell; P W M Hermans
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

6.  Protein serine/threonine kinase StkP positively controls virulence and competence in Streptococcus pneumoniae.

Authors:  Jose Echenique; Aras Kadioglu; Susana Romao; Peter W Andrew; Marie-Claude Trombe
Journal:  Infect Immun       Date:  2004-04       Impact factor: 3.441

7.  CD4-T-lymphocyte interactions with pneumolysin and pneumococci suggest a crucial protective role in the host response to pneumococcal infection.

Authors:  Aras Kadioglu; William Coward; M Joseph Colston; Colin R A Hewitt; Peter W Andrew
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  Mucosal administration of flagellin protects mice from Streptococcus pneumoniae lung infection.

Authors:  Natalia Muñoz; Laurye Van Maele; Juan M Marqués; Analía Rial; Jean-Claude Sirard; José A Chabalgoity
Journal:  Infect Immun       Date:  2010-07-19       Impact factor: 3.441

9.  Differential PsaA-, PspA-, PspC-, and PdB-specific immune responses in a mouse model of pneumococcal carriage.

Authors:  Ravichandran Palaniappan; Shailesh Singh; Udai P Singh; Senthil Kumar K Sakthivel; Edwin W Ades; David E Briles; Susan K Hollingshead; James C Paton; Jacquelyn S Sampson; James W Lillard
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 10.  Animal models of Streptococcus pneumoniae disease.

Authors:  Damiana Chiavolini; Gianni Pozzi; Susanna Ricci
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.